Pharmacist-led dermatology clinics can improve prisoners' quality of life

Pharmaceutical Journal

Volumn 272, Issue 7298, 2004, Pages 577-579

  Tucker, Rod ^a  

^a HMP Moorland   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BENZOYL PEROXIDE; CLOBETASONE BUTYRATE; COAL TAR; CORTICOSTEROID; DITHRANOL; EMOLLIENT AGENT; HYDROCORTISONE; NICOTINAMIDE; STEROID;

ACNE; ARTICLE; CLINICAL TRIAL; COMMUNITY CARE; COST EFFECTIVENESS ANALYSIS; DERMATOLOGY; ECZEMA; ELECTRONIC MEDICAL RECORD; HEALTH CARE AVAILABILITY; HEALTH CARE PLANNING; HUMAN; LEG ULCER; MALE; ONYCHOMYCOSIS; PATIENT CARE; PATIENT COUNSELING; PATIENT EDUCATION; PHARMACEUTICAL CARE; PRIMARY MEDICAL CARE; PRISON; PSORIASIS; QUALITY OF LIFE; SKIN CARE; TREATMENT OUTCOME;

EID: 2442645045     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. NHS Modernisation Agency. Action on dermatology. London: Department of Health; 2003.
2. Report on the enquiry into primary care dermatology services. Associate Parliamentary group on Skin. April 2002.
3. Report on the inquiry into the impact of skin diseases on people's lives. All Party Parliamentary Group on Skin. July 2003.
4. Bingefors K, Lindbery M, Isacson D. Self-reported dermatological problems and use of prescribed topical drugs correlate with decreased quality of life: an epidemiological survey. British Journal of Dermatology 2002;147:285-90.
5. De Arruda LHF, De Moraes APF. The impact of psoriasis on quality of life. British Journal of Dermatology 2000;144(s58):33-36.
6. Lewis-Jones S. Skin disease and disability. Dermatol Pract 1999;6:8-10.
7. Ginsburg lh, Prystowsky JH, Korfeld D, Wolland H. Role of emotional factors in adults with atopic dermatitis. International Journal of Dermatology 1993;32:656-60.
8. Woodford R, Woodford EM, Langley CA, Marriott JF, Wilson KA. Patient knowledge and acceptability of topical corticosteroid preparations: the role of the pharmacist in patient education. International Journal of Pharmacy Practice 2001;9(Suppl): R38.
9. Dermatologist calls for pharmacist prescribing to reduce GP visits. Pharmaceutical Journal 2003;270:259.
10. Plunkett A, Lau P, Stewart K, Marks R. Skin conditions in the pharmacy: consumer satisfaction and economic considerations. International Journal of Pharmacy Practice 2001;9:9-14.
11. Kilkenny M, Yeatman J, Stewart K, Marks R. Role of pharmacies and general practitioners in the management of dermatological conditions. International Journal of Pharmacy Practice 1997:5:11-15.
12. Hammarstrom B, Wessling A, Nilsson JLG. Pharmaceutical care for patients with skin diseases: a campaign year at Swedish pharmacies. Journal of Clinical Pharmacy and Therapeutics 1995;20:327-34.
13. Williams HC. Extended roles for pharmacists in caring for skin conditions: a welcome development which needs further evaluation. Journal of Clinical Pharmacy and Therapeutics 1995;20:310-12.
14. Tucker RP. Maximising the potential of prison pharmacy services. Prison Service Journal 2002;141:26-27.
15. Chu T. Antibiotic resistance and the use of combination treatments for acne. Dermatol Pract 2001;10:19-20.
16. Ozolins M, Eady EA, Avery A, Cunliffe WJ, Li Wan Po A, O'Neill C et al. A cost-effective rational for the selection of anti-microbial therapy in acne: a randomised controlled trial. British Journal of Dermatology 2002;146:542.
17. Topical steroids for atopic dermatitis in primary care. Drug and Therapeutics Bulletin 2003;41:5-8.
18. Tucker R, Exploring prisners' view of a pharmacy-led dermatology clinic. Pharmacy in Practice 2004;4:113-4.
19. Bellingham C. Time to mobilise expert patients' skills. Pharmaceutical Journal 2003;270:743-4.